Zachary R. Healy

Zachary R. Healy

Auto-generated profile, based on publicly available information

Zachary R. Healy

Department of Medicine, Duke University, Durham, NC, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PTPaul Talalay
Paul Talalay
JFJed W. Fahey
Jed W. Fahey
ZHZachary R. Healy
Zachary R. Healy
SWScott L. Wehage
Scott L. Wehage
ABAndrea L. Benedict
Andrea L. Benedict
ADAlbena T Dinkova-Kostova
Albena T Dinkova-Kostova
UV radiation (UVR) is a complete carcinogen that elicits a constellation of pathological events, including direct DNA damage, generation of reactive oxidants that peroxidize lipids and damage other cellular components, initiation of inflammation, and suppression of the immune response. Recent dramatic increases in the incidence of nonmelanoma skin cancers are largely attributable to higher exposure of an aging population to UVR. Therefore, the development of cellular strategies for intrinsic protection of the skin against the deleterious effects of UVR is imperative. Here we show that erythema resulting from UVR is a comprehensive and noninvasive biomarker for assessing UVR damage and can be precisely and easily quantified in human skin. Topical application of sulforaphane-rich extracts of 3-day-old broccoli sprouts up-regulated phase 2 enzymes in the mouse and human skin, protected against UVR-induced inflammation and edema in mice, and reduced susceptibility to erythema arising from narrow-band 311-nm UVR in humans. In six human subjects (three males and three females, 28–53 years of age), the mean reduction in erythema across six doses of UVR (300–800 mJ/cm 2 in 100 mJ/cm 2 increments) was 37.7% (range 8.37–78.1%; P = 0.025). This protection against a carcinogen in humans is catalytic and long lasting.

21 July 2026 in medRxiv
Verified
Preprint
Open access
PDF file
PMPushkar Mutha
Pushkar Mutha
JLJuyoung Lee
Juyoung Lee
GSGeorge Lucas Silva
George Lucas Silva
BDBastiaan Dreihuys
Bastiaan Dreihuys
ZHZachary Healy
Zachary Healy
Anant MadabhushiAnant Madabhushi
Anant Madabhushi
Background: Airway remodeling is a convergent feature across respiratory diseases, yet current quantitative CT tools quantify a small number of prespecified structural abnormalities of the airway tree. Radiomics of the Airway (RadAr) derives interpretable, multi-scale airway measurements from chest CT to characterize airway deformation and discover quantitative imaging biomarkers from routine chest CT. Methods: RadAr extracts over 400 multi-scale, interpretable airway measurements across lobes or generations capturing luminal dimensions, tapering, architectural distortion, and global morphology. It was evaluated in N=1331 patients across four settings: 63-week mortality prediction in fibrotic interstitial lung disease (fILD), COVID-19 severity prediction, structure-function association in progressive pulmonary fibrosis (PPF) and structure-inflammation markers in pediatric cystic fibrosis (CF). Unsupervised clustering was used to identify airway phenotypes across the fILD and COVID-19 cohorts. Results: In fILD, lower-lobe architectural distortion was associated with mortality (balanced accuracy 0·654). In COVID-19, severe disease was independently associated with luminal dilation (AUC 0·719, odds ratio 2·32, p=0·017). In PPF, airway phenotypes correlated with forced vital capacity (ρ=0·83), mid-expiratory flow (ρ=0·87), and ¹²⁹Xe MRI alveolar gas exchange impairment (ρ=0·70). In pediatric CF, reduced tapering and increased cylindricity were associated with prior exacerbations and bronchoalveolar lavage neutrophilia (ρ=-0·64 to -0·78). Five phenotypes were identified from extensive, tapered airway trees to sparse, dilated, thick-walled, tortuous trees, with increasing COVID-19 severity and fILD mortality across this spectrum. Conclusion: RadAr identified interpretable, disease-specific airway phenotypes associated with function and outcomes across restrictive, obstructive, and mixed lung diseases in adult and pediatric settings. These findings establish a framework for discovery and development of quantitative airway biomarkers for patient stratification, disease monitoring, or imaging endpoint development in pulmonary trials.

17 August 2023
Verified
Preprint
Open access
PDF file
ZHZachary R Healy
Zachary R Healy
DMDavid Murdoch
David Murdoch
ACAlicia Cooper-Volkheimer
Alicia Cooper-Volkheimer
This protocol describes the T/NK Immunosenescence Profiling Flow Cytometry Panel

17 August 2023
Verified
Preprint
Open access
PDF file
ZHZachary R Healy
Zachary R Healy
DMDavid Murdoch
David Murdoch
ACAlicia Cooper-Volkheimer
Alicia Cooper-Volkheimer
This protocol describes the Intracellular Staining (ICS) Senescence Flow Cytometry Panel